Emcure Pharmaceuticals Limited (NSE:EMCURE)
India · Delayed Price · Currency is INR 2,334.40
+102.00 (4.57%)
Nov 12, 2026, 3:30 PM IST
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 442.79 billion as of November 12, 2026. It is the 3,893rd most valuable company in the world and the 231st biggest in India. Its market cap has increased by 70.54% in one year.
Market Cap
442.79B
Enterprise Value
458.88B
Revenue
102.34B
Global Rank
Country Rank
#231 India
PE Ratio
40.50
ChartMarket Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 442.79B, an increase of 72.32%. That is a compound annual growth rate of 26.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 442.79B | 71.18% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Glenmark Pharmaceuticals | 755.56B |
| Alkem Laboratories | 651.39B |
| Gland Pharma | 537.79B |
| Ipca Laboratories | 492.19B |
| Ajanta Pharma | 414.79B |
| Wockhardt | 329.86B |
| Piramal Pharma | 326.07B |
| Alembic Pharmaceuticals | 202.36B |